Roche receives FDA clearance on its digital pathology solution for diagnostic use

The solution, which includes the VENTANA DP 200 slide scanner, Roche’s digital pathology workflow software and a display, is now cleared to aid in clinical diagnosis, enabling pathologists to diagnose patients using digital images.
Primary diagnosis for digital pathology enhances healthcare efficiency and helps ensure effective and timely patient care, especially in areas where access to pathologists is limited.
This clearance is a foundational step in Roche’s commitment to enable routine clinical diagnosis with its digital pathology solutions.

LabNews Media LLC

The Editors in Chief of lab-news.de are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu

Roche receives FDA clearance on its digital pathology solution for diagnostic use

LabNews Media LLC

Stay Connected

Unmatched reporting

Roche receives FDA clearance on its digital pathology solution for diagnostic use

LabNews Media LLC

Ähnliche Beiträge

Neue Epstein-Akten nennen weitere prominente Namen

Explodierende Kosten der Beamtenpensionen im Vergleich zur gesetzlichen Rente

Tödliche Hasenpest: Drei Menschen in Niedersachsen und Bremen infiziert

Stay Connected

Unmatched reporting